The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Gastrin and colorectal cancer: A prospective study
Open accessAbstract
BACKGROUND & AIMS: Gastrin is a putative promoter of colorectal carcinomas. The aim of this study was to evaluate the temporal relationship between gastrinemia and development of colorectal malignancy. METHODS: We conducted a nested case-control study among 128,992 subscribers to a health maintenance program who had participated in a multiphasic health checkup between 1964 and 1969. Serum had been frozen since the checkup and the cohort followed up for cancer. Of 1881 incident colorectal carcinoma cases, 250 were randomly selected; 1 control without cancer was matched to each case by age, sex, education, and date of serum collection. Stored sera were tested for Helicobacter pylori immunoglobulin G and for gastrin and glycine-extended gastrin. RESULTS: Verified cases included 166 colon cancers, 58 rectal cancers, and 9 with cancer in both locations. A mean of 15.3 years had elapsed between serum collection and diagnosis of cancer. Median gastrin levels were similar in cases and controls (41.7 vs. 40.7 pg/mL). However, a gastrin level above normal was associated with increased risk for colorectal malignancy (odds ratio, 3.9; 95% confidence interval, 1.5-9.8). If this association is causal, 8.6% of colorectal cancers could be attributed to high serum gastrin level. CONCLUSIONS: Hypergastrinemia is associated with an increased risk of colorectal carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Last, chronic hypergastrinemia, typically present during PPI use, can promote the growth of malignant colonic epithelial cells, facilitating the deleterious sequencing adenoma-carcinoma[151-153].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., FRIEDMAN, G. D., Vandersteen, D. P., Chang, Y., Vogelman∥, J. H., Orentreich∥, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,893
Self-citationColon Cancer: A Review of the Epidemiology
Potter, J. D., Slattery, M. L., Bostick, R. M., & Gapstur, S. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036132 · Cited by 767
Intestinal floras of populations that have a high risk of colon cancer
Moore, W. E., & Moore, L. H. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.9.3202-3207.1995 · Cited by 483
Giovannucci, E. L., Colditz, G. A., Stampfer, M. J., Hunter, D., ROSNER, B. A., Willett, W. C., & Speizer, F. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.3.192 · Cited by 423
Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
Lamberts, R., Creutzfeldt, W., Strüber, H. G., Brunner, G. H. G., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90344-c · Cited by 322
Lanzon-Miller, S., Pounder, R. E., Hamilton, M., BALL, S., Chronos, N., Raymond, F. D., Olausson, M., & Cederberg, C. (1987) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1987.tb00623.x · Cited by 188
Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat
Ryberg, B., Axelson, J., Håkanson, R., Sundler, F., & Mattsson, H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91287-g · Cited by 158
Pentagastrin-induced stimulation of protein synthesis in the gastrointestinal tract
Johnson, L., Aures, D., & Yuen, L. (1969) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1969.217.1.251 · Cited by 135
Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells
Sirinek, K. R., Levine, B. A., & Moyer, M. P. (1985) · The American Journal of Surgery · doi:10.1016/s0002-9610(85)80006-4 · Cited by 120
Cigarette Smoking and Alcohol Consumption as Risk Factors for Colorectal Adenomatous Polyps
Martinez, M. E., McPherson, R. S., Annegers, J. F., & Levin, B. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.274 · Cited by 113
Research works printed but not linked: 1
- McCloy, 1992, Implications of a review of long-term safety of omeprazole and management strategies for peptic disease, Hepatogastroenterology, 39, 90
Cited by
Sorted by citations
Freedberg, D. E., Kim, L. S., & Yang, Y. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 933
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Zollinger-Ellison Syndrome: Clinical Presentation in 261 Patients
Roy, P. K., Venzon, D. J., Shojamanesh, H., Abou‐Saif, A., Peghini, P. L., Doppman, J. L., Gibril, F., & Jensen, R. T. (2000) · Medicine · doi:10.1097/00005792-200011000-00004 · Cited by 347
The Gastrins: Their Production and Biological Activities
Dockray, G. J., Varró, A., Dimaline, R., & Wang, T. C. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.119 · Cited by 346
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Sheen, E., & Triadafilopoulos, G. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1560-3 · Cited by 316
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Gut microbiota, inflammation and colorectal cancer
Sun, J., & Kato, I. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.03.004 · Cited by 257
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Safety of Proton Pump Inhibitor Exposure
Yang, Y., & Metz, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.023 · Cited by 211
Gastrin, CCK, Signaling, and Cancer
Rozengurt, E., & Walsh, J. H. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.49 · Cited by 207
Long-term Safety Concerns with Proton Pump Inhibitors
Ali, T., Roberts, D. N., & Tierney, W. M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.014 · Cited by 197
Role of Bacteria in Oncogenesis
Chang, A. H., & Parsonnet, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-10 · Cited by 202
“pylori infection was not linked to colorectal cancer, despite being correlated highly with hypergastrinemia (244).”
BackgroundHelicobacter pylori is a Risk Factor for Colonic Neoplasms
Sonnenberg, A., & Genta, R. M. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.407 · Cited by 181
Sawyer, J. R., Husain, M., Pravdenkova, S. V., Krisht, A. F., & Al‐Mefty, O. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2 · Cited by 55
Burnett‐Hartman, A. N., Newcomb, P. A., & Potter, J. D. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0571 · Cited by 157
“Several studies found a positive association between hypergastrinemia and colorectal neoplasia (22, 28, 33), including a prospective study assessing serum gastrin levels prior to the diagnosis of colorectal carcinoma (OR=3.”
BackgroundRelationship between Helicobacter pylori CagA status and colorectal cancer
Shmuely, H., Passaro, D., Figer, A., Niv, Y., Pitlik, S. D., Samra, Z., Koren, R., & Yahav, J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05342.x · Cited by 153
“(8), in a larger study, noted no such association.”
BackgroundGastrins, cholecystokinins and gastrointestinal cancer
Aly, A., Shulkes, A., & Baldwin, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.01.004 · Cited by 144
Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study
Robertson, D. J., Larsson, H., Friis, S., Pedersen, L., Baron, J. A., & Sørensen, H. T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.014 · Cited by 139
Helicobacter pylori Infection and Colorectal Cancer Risk: A Meta‐Analysis
Zumkeller, N., Brenner, H., Zwahlen, M., & Rothenbacher, D. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00381.x · Cited by 136
Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., Propert, K., Hwang, W., Sedarat, A., & Lewis, J. D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.022 · Cited by 125
Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues
Thomas, R. P., Hellmich, M. R., Townsend, C. M., & Evers, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0028 · Cited by 119
Gastrin as a growth factor in the gastrointestinal tract
Koh, T. J., & Chen, D. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00176-2 · Cited by 118
Zhang, Y., Hoffmeister, M., Weck, M. N., Chang-Claude, J. C., & Brenner, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr331 · Cited by 117
Butt, J., Varga, M. G., Blot, W. J., Teras, L., Visvanathan, K., Le Marchand, L., Haiman, C., Chen, Y., Bao, Y., Sesso, H. D., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.09.054 · Cited by 114
Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes
Zeng, Q., Ou, L., Wang, W., & Guo, D.-Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00112 · Cited by 112
Helicobacter pyloriInfection and the Risk of Development of Esophageal Adenocarcinoma
de Martel, C., Llosa, A. E., Farr, S. M., FRIEDMAN, G. D., Vogelman∥, J. H., Orentreich∥, N., Corley, D. A., & Parsonnet, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/427659 · Cited by 112
“pylori infection and either gastric cancer or gastric lymphoma [18, 19], have been identified through nested casecontrol studies of the multiphasic health checkup (MHC) cohort of the Kaiser Permanente Medical Care Program (KPMCP) [18-22].”
BackgroundSelf-citationReview article: historic changes of Helicobacter pylori -associated diseases
Sonnenberg, A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12380 · Cited by 111
Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies
Ahn, J. S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i16.2560 · Cited by 109
Phase II Study of Anti–Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer
Brett, B. T., Smith, S. C. L., Bouvier, C., Michaeli, D., Hochhauser, D., Davidson, B. R., Kurzawinski, T. R., Watkinson, A. F., van Someren, N., Pounder, R. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.151 · Cited by 109
Schlom, J., Hodge, J. W., Palena, C., Tsang, K.-Y., Jochéms, C., Greiner, J. W., Farsaci, B., Madan, R. A., Heery, C. R., & Gulley, J. L. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00002-0 · Cited by 103
Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence
Smith, A. M., & Watson, S. A. (2000) · Gut · doi:10.1136/gut.47.6.820 · Cited by 106
“Long term exposure to hypergastrinaemia, due to increased cell turnover of the mucosa, may increase the chance of a spontaneous mutation and eventual tumour formation. This was confirmed in a recent nested case control study by Thorburn and colleagues.”
ResultSingh, P., Velasco, M. A. D., Given, R. L., Varró, A., & Wang, T. C. (2000) · Gastroenterology · doi:10.1053/gast.2000.8527 · Cited by 106
Seroprevalence of helicobacter pylori in patients with colorectal polyps and colorectal carcinoma
Siddheshwar, R. K., Muhammad, K. B., Gray, J., & Kelly, S. B. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02148-1 · Cited by 103
Pradeep, A., Sharma, C., Sathyanarayana, P., Albanese, C., Fleming, J. V., Wang, T. C., Wolfe, M. M., Baker, K. M., Pestell, R. G., & Rana, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207454 · Cited by 103
“A recent epidemiological study showed that prolonged hypergastrinemia increased the relative risk of developing colon cancer by 3.3-fold (Thorburn et al., 1998).”
BackgroundInfluentialWu, Q., Yang, Z., Xu, P., Gao, L., & Fan, D. (2013) · Colorectal Disease · doi:10.1111/codi.12284 · Cited by 102
Smith, A. M., & Watson, S. A. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00842.x · Cited by 98
Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer
Hartwich, A., Konturek, S. J., Pierzchalski, P., Żuchowicz, M., Labza, H., Konturek, P. C., Karczewska, E., Bielański, W., Marlicz, K., Starzyñska, T., et al. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840100288 · Cited by 97
“However, the fact that this infection is accompanied by an increased plasma level of gastrin, as reported previously [27, 30 , 32] and also observed in this study, suggests that this hormone could contribute to the colorectal cancerogenesis by inducing higher mucosal cell proliferation in the colon [18].”
ResultHypergastrinemia Is Associated with Increased Risk of Distal Colon Adenomas
Georgopoulos, S. D., Polymeros, D., Triantafyllou, K., Spiliadi, C., Mentis, A., Karamanolis, D. G., & Ladas, S. D. (2006) · Digestion · doi:10.1159/000096593 · Cited by 90
“and that subjects with gastrin levels above normal limits have a 3.9-fold risk for CRC development [”
BackgroundInfluentialWatson, S., & Smith, A. M. (2001) · PubMed · Cited by 89
Zhao, Y., Wang, F., Chang, D. K., Han, B., & You, D. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0479-z · Cited by 87
“Of the 13 studies, two were nested case–control studies [30], and one only chose male smokers as subjects [16].”
BackgroundResultSiddheshwar, R. K., Gray, J. C., & Kelly, S. B. (2001) · Gut · doi:10.1136/gut.48.1.47 · Cited by 84
Proton Pump Inhibitors and the Risk of Colorectal Cancer
van Soest, E. M., van Rossum, L. G. M., Dieleman, J. P., van Oijen, M. G. H., Siersema, P. D., Sturkenboom, M. C. J. M., & Kuipers, E. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01665.x · Cited by 80
“One large epidemiological study showed a greater risk of colorectal malignancies in patients with gastrin levels above normal (14).”
BackgroundHong, S. N., Lee, S. M., Kim, J. H., Lee, T. Y., Kim, J. H., Choe, W. H., Lee, S., Cheon, Y. K., Sung, I. K., Park, H. S., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2245-x · Cited by 79
“[34] showed that serum hypergastrinemia was associated with a 3.”
BackgroundHelicobacter pylori Infection and Development of Pancreatic Cancer
de Martel, C., Llosa, A. E., Friedmana, G. D., Vogelman∥, J. H., Orentreich∥, N., Stolzenberg‐Solomon, R. Z., & Parsonnet, J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0185 · Cited by 79
“Gender,* n (%) Female 69 (49) 334 (46) 69 (58) 62 (34) 116 (51) 87 (43) Male 72 (51) 395 (54) 49 (42) 117 (65) 112 (49) 117 (57) Race,* n (%) Missing 1 (1) 4 (1) 0 0 3 (1) 1 (0) Black 28 (20) 103 (14) 10 (8) 35 (19) 18 (8) 40 (20) White 109 (77) 601 (82) 98 (83) 142 (79) 198 (87) 163 (80) Other 3 (2) 22 (3) 10 (8) 3 (…”
Self-citationThe Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
Smith, J. P., Fonkoua, L. A. K., & Moody, T. W. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14952 · Cited by 80
“A large study of nearly 130,000 patients with Helicobacter pylori infections reported an approximate 4-fold increase in colorectal cancers in those with elevated gastrin levels [25].”
BackgroundMortality study of 18 000 patients treated with omeprazole
Bateman, D. N., Colin-Jones, D. G., Hartz, S. C., Langman, M. J. S., Logan, R. F., Mant, J., Murphy, M., Paterson, K. R., Rowsell, R., Thomas, S., et al. (2003) · Gut · doi:10.1136/gut.52.7.942 · Cited by 78
Singh, P., Velasco, M. A. D., Given, R. L., Wargovich, M. J., Varró, A., & Wang, T. C. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g390 · Cited by 75
“In a recent prospective study, amidated gastrin and Gly-gastrin were measured in the serum of a large number of patients, some of whom eventually developed colorectal carcinomas (46).”
BackgroundResultHelicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers.
Limburg, P. J., Stolzenberg‐Solomon, R. Z., Colbert, L. H., Perez-Perez, G. I., Blaser, M. J., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2002) · PubMed · Cited by 74
CCK‐B/gastrin receptors in human colorectal cancer
Schmitz, F., Otte, J. ‐., Stechele, H. U., Reimann, B., Banasiewicz, T., Fölsch, U. R., Schmidt, W. E., & Herzig, K. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00870.x · Cited by 74
Dockray, G. J. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.07.003 · Cited by 73
Potential adverse effects of proton pump inhibitors
Coté, G. A., & Howden, C. W. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0045-4 · Cited by 69
Glycine-Extended Gastrin Exerts Growth-Promoting Effects on Human Colon Cancer Cells
Stepan, V. M., Sawada, M., Todisco, A., & Dickinson, C. J. (1999) · Molecular Medicine · doi:10.1007/bf03402058 · Cited by 69
Self-citationColucci, R., Blandizzi, C., Tanini, M., Vassalle, C., Breschi, M. C., & Tacca, M. D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706053 · Cited by 68
“…cancer, and it has been proposed that CCK-2 receptors may mediate direct inhibitory or growth factor-dependent stimulant actions on cell growth (Varro et al., 2002); (3) some models of intestinal epithelial cells do not express CCK-2 receptors and need to be transfected to examine the effects…”
BackgroundHelicobacter pylori but not gastrin is associated with the development of colonic neoplasms
Selgrad, M., Bornschein, J., Kandulski, A., Hille, C., Weigt, J., Roessner, A., Wex, T., & Malfertheiner, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.28758 · Cited by 68
“Gastrin is capable of stimulating growth factor dependent signaling pathways and therefore hypergastrinemia may act as a putative promoter of colorectal neoplasia in humans.(15) In vitro, high gastrin levels have been shown to be associated with growth and proliferation of colon cancer cells.”
BackgroundChen, X.-Z., Schöttker, B., Castro, F. A., Chen, H., Zhang, Y., Holleczek, B., & Brenner, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7946 · Cited by 69
Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome
Singh, A., Cresci, G., & Kirby, D. F. (2018) · Nutrition in Clinical Practice · doi:10.1002/ncp.10181 · Cited by 69
Jensen, R. T. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910611.x · Cited by 68
Sarri, B., Canonge, R., Audier, X., Simon, E., Wojak, J., Caillol, F., Cador, C., Marguet, D., Poizat, F., Giovannini, M. F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46489-x · Cited by 67
Inoue, I., Mukoubayashi, C., Yoshimura, N., Niwa, T., Deguchi, H., Watanabe, M., Enomoto, S., Maekita, T., Ueda, K., Iguchi, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25931 · Cited by 67
Subramaniam, D., Ramalingam, S., May, R. J., Dieckgraefe, B. K., Berg, D. E., Pothoulakis, C., Houchen, C. W., Wang, T. C., & Anant, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.040 · Cited by 68
Association between Helicobacter pylori infection and the risk of colorectal cancer
Zuo, Y., Zhao, J., Bie, M., Xu, C., Hao, X., & Wang, B. (2020) · Medicine · doi:10.1097/md.0000000000021832 · Cited by 64
Kim, T. J., Kim, E. R., Chang, D. K., Kim, Y., Baek, S., Kim, K., & Hong, S. N. (2017) · Helicobacter · doi:10.1111/hel.12377 · Cited by 64
Chronic Hypergastrinemia: Causes and Consequences
Orlando, L. A., Lenard, L. G., & Orlando, R. C. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9419-3 · Cited by 63
“I carcinogen by the World Health Organization [64].”
BackgroundHelicobacter pyloriand colorectal neoplasia: Is there a causal link?
Papastergiou, V. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.649 · Cited by 62
Atrophic Gastritis, Helicobacter pylori , and Colorectal Cancer Risk: A Case‐Control Study
Montani, A., Sasazuki, S., Inoue, M., Natsukawa, S., Shaura, K., Koizumi, Y., Kasuga, Y., Hanaoka, T., & Tsugane, S. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00513.x · Cited by 61
Mechanism of Activation of Protein Kinase D2(PKD2) by the CCKB/Gastrin Receptor
Sturany, S., Lint, J. V., Gilchrist, A., Vandenheede, J. R., Adler, G., & Seufferlein, T. T. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200934200 · Cited by 61
Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus
Wang, J. S., Varró, A., Lightdale, C. J., Lertkowit, N., Slack, K. N., Fingerhood, M., Tsai, W. Y., Wang, T. C., & Abrams, J. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.629 · Cited by 58
Mizuno, S., Morita, Y., Inui, T., Asakawa, A., Ueno, N., Ando, T., Kato, H., Uchida, M., Yoshikawa, T., & Inui, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21280 · Cited by 57
“sae and with an increased risk of colonic malignancy in a subpopulation of patients.(6,15) The way in which H.”
BackgroundFerrand, A., Bertrand, C., Portolan, G., Cui, G., Carlson, J. E., Pradayrol, L., Fourmy, D., Dufresne, M., Wang, T. C., & Seva, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0978 · Cited by 56
“In addition, a recent study suggests that the risk for developing colorectal carcinoma is increased in patients with hypergastrinemia (46).”
BackgroundGastrin, inflammation, and carcinogenesis
Chao, C., & Hellmich, M. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328333faf8 · Cited by 56
Helicobacter pylori Protein–Specific Antibodies and Risk of Colorectal Cancer
Epplein, M., Pawlita, M., Michel, A., Peek, R. M., Cai, Q., & Blot, W. J. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0702 · Cited by 53
“An association between highgastrin levels and colorectal cancer risk has been suggested in several studies of human populations (28–30), although the association only reached significance in one study (30).”
Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms
Nam, J. H., Hong, C. W., Kim, B. C., Shin, A., Ryu, K. H., Park, B.-J., Kim, B., Sohn, D. K., Han, K. S., Kim, J., et al. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0839-x · Cited by 53
“pylori-induced hypergastrinemia stimulates colonic carcinogenesis by cell proliferation, and some studies have supported this claim [20, 28].”
Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa
Schmassmann, A., & Reubi, J. C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8115 · Cited by 54
“The growth-promoting effect of gastrin (18–20) has generated substantial interest because of potential side effects such as gastric or colorectal tumor growth during hypergastrinemia induced by long-term treatment with gastric acid-inhibitory drugs (38, 39).”
BackgroundChoi, D. S., Seo, S. I., Shin, W. G., & Park, C. H. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000127 · Cited by 51
“1998 Thorburn (37) Case-control USA 1964–1991 466 Community-based IgG anti-HP antibody N/A 9”
BackgroundInfluentialAssociation of Helicobacter Pylori Infection and Colon Cancer
Strofilas (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr880w · Cited by 51
“differ between the two groups, in accordance to numerous previous case-control studies [30-33].”
ResultRole of gastrin peptides in carcinogenesis
Grabowska, A. M., & Watson, S. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.017 · Cited by 51
Association of Helicobacter pylori Infection With Colon Cancer and Adenomatous Polyps.
Teimoorian, F., Ranaei, M., Hajian‐Tilaki, K., Shokri‐Shirvani, J., & Vosough, Z. (2018) · Europe PMC (PubMed Central) · Cited by 51
Gastrin, Helicobacter pylori, and Colorectal Adenomas
Robertson, D. J., Sandler, R. S., Ahnen, D. J., Greenberg, E. R., Mott, L. A., Cole, B. F., & Baron, J. A. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.09.006 · Cited by 50
Cobb, S., Wood, T. G., Ceci, J. D., Varró, A., Velasco, M. A. D., & Singh, P. (2004) · Cancer · doi:10.1002/cncr.20094 · Cited by 50
Expression of gastrin and its receptor in human gastric cancer tissues
Hur, K., Kwak, M. K., Lee, H.-J., Park, D. J., Lee, H. K., Lee, H. S., Kim, W. H., Michaeli, D., & Yang, H. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0043-y · Cited by 49
“However, little information is available on the expression of gastrin/CCKB receptor protein in gastric carcinoma tissues, although a previous epidemiological study demonstrated that above-normal gastrin levels are associated with an increased risk of colorectal malignancy (Thorburn et al. 1998).”
ResultPhase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer.
Smith, A. M., Justin, T. A., Michaeli, D., & Watson, S. A. (2000) · PubMed · Cited by 49
Siersema, P. D., Yu, S., Sahbaie, P., Steyerberg, E. W., Simpson, P. W., Kuipers, E. J., & Triadafilopoulos, G. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.043 · Cited by 47
Personal review: is profound acid inhibition safe?
Waldum, H. L., & Brenna (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00681.x · Cited by 47
Gastroesophageal reflux disease
Rai, A. M., & Orlando, R. C. (2001) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200107000-00011 · Cited by 47
Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1
Song, D. H., Rana, B., Wolfe, J. R., Crimmins, G. M., Choi, C. J., Albanese, C., Wang, T. C., Pestell, R. G., & Wolfe, M. M. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00516.2002 · Cited by 47
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence
Watson, S. A., Morris, T. M., McWilliams, D. F., Harris, J. C., Evans, S. A., Smith, A. M., & Clarke, P. A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600509 · Cited by 46
“…a positive temporal relationship has been observed between hyper-gastrinaemia and increased incidence of colon cancer with 8.9% of colon cancer being shown to be attributable to elevated gastrin levels (Thorburn et al, 1998), indicating a sub-group of patients exhibiting increased sensitivity.”
BackgroundMethodInfluentialThe relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis
Rokkas, T., Sechopoulos, P., Pistiolas, D., Kothonas, F., Margantinis, G., & Koukoulis, G. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328363d3cd · Cited by 42
Bierkamp, C., Kowalski‐Chauvel, A., Dehez, S., Fourmy, D., Pradayrol, L., & Seva, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205999 · Cited by 42
“…that, both gastrin and CCK-2R are often upregulated in human carcinomas and precancerous lesions of the gastrointestinal tract and that in an epidemiological study increased colorectal cancer risk has been attributed to prolonged hypergastrinemia (Smith and Watson, 2000a,b; Thorburn et al., 1998).”
BackgroundAbbass, K., Gul, W., Beck, G., Markert, R. J., & Akram, S. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e31821e9009 · Cited by 41
Colorectal cancer risk in relation to use of acid suppressive medications
Chubak, J., Boudreau, D. M., Rulyak, S. J., & Mandelson, M. T. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1749 · Cited by 40
Hu, K., Wu, M., Chu, C., Wang, H., Lin, S., Liu, C., Su, T., Liao, W., Chen, C., Liu, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy591 · Cited by 39
Somatostatin inhibits colon cancer cell growth through cyclooxygenase‐2 downregulation
Colucci, R., Blandizzi, C., Ghisu, N., Florio, T., & Tacca, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.268 · Cited by 41
“…suggest that hypergastrinaemia is associated with an increased risk of colorectal cancer, and it has been observed that most patients with colorectal cancer may present an increased expression of gastrin receptors and COX-2 in their neoplastic tissues (Thorburn et al., 1998; Hartwich et al., 2001).”
BackgroundIdentification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells
Schmitz, F., Schrader, H., Otte, J., Schmitz, H., Stuber, E. R., Herzig, K., & Schmidt, W. E. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00281-6 · Cited by 40
Chen, Y., Xu, S., Ding, Y., Huang, X., & Deng, B. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7613 · Cited by 39
“Several studies have evaluated this hypothesis and have found increased levels of circulating gastrin in patients colonized with H. pylori who are diagnosed with colorectal cancer (Thorburn et al., 1998; A. Hartwich et al., 2001; Georgopoulos et al., 2006).”
BackgroundKhajeh, S., Tohidkia, M. R., Aghanejad, A., Mehdipour, T., Fathi, F., & Omidi, Y. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1478846 · Cited by 39
“Different cumulative in vitro studies have shown that G17-Gly promotes proliferation of different GI cell lines including pancreatic carcinoma cell line (AR4–2J) [4], gastric carcinoma cell lines (AGS and SIIA), and colon carcinoma cell lines (HCT-116, LoVo and HT29) [5].”
BackgroundChao, C., Goluszko, E., Lee, Y.-T., Kolokoltsov, A. A., Davey, R. A., Uchida, T., Townsend, C. M., & Hellmich, M. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209862 · Cited by 39
“%) for developing colorectal cancer (Thorburn et al., 1998).”
Role of gastrin-peptides in Barrett's and colorectal carcinogenesis
Chueca, E. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6560 · Cited by 38
Hu, K., Wu, M., Chu, C., Wang, H., Lin, S., Liu, S.-C., Liu, C., Su, T., Chen, C., Liu, C., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00257 · Cited by 34
“(28) reported that hypergastrinemia may promote colorectal neoplasia in humans, because gastrin is capable of stimulating growth factor–dependent signaling pathways.”
Yang, F., Xu, Y.-L., & Zhu, R. (2019) · Minerva Medica · doi:10.23736/s0026-4806.19.05942-1 · Cited by 37
Zumkeller, N., Brenner, H., Chang-Claude, J. C., Hoffmeister, M., Nieters, A., & Rothenbacher, D. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.005 · Cited by 37
Metadata
- Authors
- Thorburn*, C. M., Friedman‡, G. D., Dickinson§, C. J., Vogelman∥, J. H., Orentreich∥, N., & Parsonnet*, #.
- Affiliations
- Kaiser Permanente (US)
- Stanford University (US)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1998-08
- Volume
- 115
- Issue
- 2
- Pages
- 275-280
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2029989332
- Cited by
- 267
- References
- 42
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 7 · 2020: 14 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 13 · 2015: 1 · 2014: 7 · 2013: 19 · 2012: 12
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r03ca065801-01a1, DK34933)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Keywords
- gastrin, hypergastrinemia, colorectal cancer, colon cancer, rectal cancer, serum gastrin, cancer risk, Helicobacter pylori, glycine-extended gastrin, temporal relations
- MeSH terms
- Colonic Neoplasms, Female, Gastrins, Humans, Male, Middle Aged, Prospective Studies, Rectal Neoplasms, Risk Factors, Colorectal Neoplasms, Cohort Studies, Incidence, Multivariate Analysis, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
